The WOLA provides policy recommendations for developing and implementing gender-sensitive drug and prison-related policies rooted in human rights and public health.
GDPO provides a critical reading of 'development-orientated drug policies', underscoring the importance of focusing on the socio-structural drivers of involvement in illicit drug markets.
The HIV Legal Network urges local authorities to use flexibilities within their power to undo the damage of criminalisation on people who use drugs, until legislation is changed federally.
IDPC, WOLA and PRI note an alarming rise in female incarceration rates in Latin America since 2000, putting countless women at risk of abuse and exacerbating the vulnerabilities they face in society.
OPIS argues evidence for the therapeutic potential of psilocybin in addressing this debilitating condition warrants immediate reform to allow for legal access and further research.
Madden et al. shed light on the discursive, material and procedural barriers hindering the meaningful engagement of people who use drugs in UN drug-policy, while identifying strategies for resistance and change.
HRI provide a thorough analysis of global harm reduction provision, highlighting innovations and barriers as well as the need for substantial investment.
The Canadian Drug Policy Coalition provides an overview of drug-related challenges in Canada and pathways toward sustainable solutions anchored in public health and harm reduction.
AFEW's survey sheds light on the impact of the COVID-19 pandemic and associated restrictions on civil society in terms of their staff's health, operations and sustainability.
